Characteristics of lipid metabolism in patients with acromegaly

DOI: https://doi.org/10.29296/25877305-2018-07-12
Download full text PDF
Issue: 
7
Year: 
2018

Yu. Zavyalova, Candidate of Medical Sciences; E. Mikhailova, Candidate of Medical Sciences City Clinical Hospital Twelve, Nizhny Novgorod

The paper considers the characteristics of lipid metabolism in patients with acromegaly; their relationship to duration and to the hormonal activity of somatotropinoma.
Keywords: 
endocrinology
acromegaly
lipid metabolism
atherosclerosis

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Ametov A.S., Doskina E.V. Akromegalija i gigantizm / M.: GEOTAR-Media, 2010; s. 76.
  2. Dedov I.I., Molitvoslovova N.N., Marova E.I. Akromegalija: patogenez, klinika, diagnostika, differentsial'naja diagnostika, metody lechenija. Posobie dlja vrachej / Tver': Triada, 2006; 48 s.
  3. Clayton R. Cardiovascular function in acromegaly // Endocr. Rev. – 2003; 24: 272–7.
  4. Colao A., Feroni D., Marzullo P. et al. Complications of Acromegaly: Epidemiology, Pathogenesis and Management // Endocr. Rev. – 2011; 1: 102–52.
  5. Colao A., Marzullo P., Di Somma C. Grown hormone and the heart // Clin. Endocrinol. – 2005; 54: 137–54.
  6. Ferrari A., Modifications of the cardiovascular system with aging // Am. J. Geriatr. Cardiol. – 2012; 11: 30–3.
  7. Lombardi G., Galdiero M., Colao A. Acromegaly and the cardiovascular system // Neuroendocrinology. – 2006; 83: 211–7.
  8. Akutsu H., Kreutzer J., Wasmeier G. et al. Acromegaly per se does not increase the risk for coronary artery disease // Eur. J. Endocrinol. – 2010; 162: 879–86.
  9. Jarkova N.A., Borovkov N.N., Amineva N.V. Rol' arterial'noj gipertenzii v razvitii hronicheskoj bolezni pochek u bol'nyh saharnym diabetom 2-go tipa // Med. al'manah. – 2013; 6 (30): 173–5.